Compounds > mci-196
Page last updated: 2024-08-24

mci-196 and Hyperphosphatemia

mci-196 has been researched along with Hyperphosphatemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's8 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J1
Bai, Q; Guo, H; Li, Y; Liu, H; Yang, X; Zhang, X1
Dimkovic, N; Locatelli, F; Spasovski, G2
Dellanna, F; Dimkovic, N; Locatelli, F; Pontoriero, G; Spasovski, G; Wanner, C1
Dimkovic, N; Hertel, J; Locatelli, F; Spasovski, G; Wanner, C1
Chen, J; Li, M; Zhang, Q1
Dimkovic, N; Locatelli, F; Spasovski, G; Wanner, C1
Akizawa, T; Mizobuchi, M; Sanada, D1
Dimkovic, N; Kostic, S; Locatelli, F; Manning, A; Nakajima, S; Pljesa, S; Pontoriero, G; Sano, H; Spasovski, G1

Reviews

4 review(s) available for mci-196 and Hyperphosphatemia

ArticleYear
Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease.
    JPEN. Journal of parenteral and enteral nutrition, 2018, Volume: 42, Issue:4

    Topics: Bile Acids and Salts; Calcium; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Iron; Iron Compounds; Niacin; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic

2018
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10

    Topics: Bile Acids and Salts; Calcium; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic

2014
Effect of colestilan on serum phosphorus in dialysis patients: A meta-analysis of the literature.
    Nephrology (Carlton, Vic.), 2016, Volume: 21, Issue:3

    Topics: Bile Acids and Salts; Biomarkers; Chelating Agents; Chi-Square Distribution; Humans; Hyperphosphatemia; Odds Ratio; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Time Factors; Treatment Outcome

2016
[Novel phosphate binders under development].
    Clinical calcium, 2009, Volume: 19, Issue:2

    Topics: Bile Acids and Salts; Chronic Disease; Citric Acid; Clinical Trials as Topic; Drug Design; Ferrous Compounds; Humans; Hyperphosphatemia; Kidney Diseases; Polyamines; Risk Factors; Sevelamer

2009

Trials

6 trial(s) available for mci-196 and Hyperphosphatemia

ArticleYear
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12, Issue:2

    Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer

2008
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:7

    Topics: Bile Acids and Salts; Dose-Response Relationship, Drug; Double-Blind Method; Dyslipidemias; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors

2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Calcium; Cholesterol; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Young Adult

2014
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
    Nephron, 2015, Volume: 130, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult

2015
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia.
    Blood purification, 2016, Volume: 41, Issue:4

    Topics: Adult; Aged; Bile Acids and Salts; Cholesterol, LDL; Diarrhea; Female; Glycated Hemoglobin; Hemodialysis Solutions; Humans; Hyperphosphatemia; Male; Middle Aged; Nausea; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Renal Dialysis; Renal Insufficiency, Chronic; Uric Acid; Vomiting

2016
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:2

    Topics: Adult; Aged; Bile Acids and Salts; Cholesterol; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Renal Dialysis; Young Adult

2010